Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content


Hot Topics of the Day|PHGKB
Search PHGKB:

Archive

Hot Topics of the Day are picked by experts to capture the latest information and publications on public health genomics and precision health for various diseases and health topics. Sources include published scientific literature, reviews, blogs and popular press articles.

Search Archive:
42 hot topic(s) found with the query "Hiv/aids"

National Women and Girls HIV/AIDS Awareness Day
CDC, March 10, 2019 (Posted: Mar 08, 2019 11AM)

Molecular Signatures of HIV-1 Envelope Associated with HIV-Associated Neurocognitive Disorders.
Evering Teresa H et al. Current HIV/AIDS reports 2018 Feb (Posted: Mar 05, 2018 9AM)

Genetic Cluster Analysis for HIV Prevention.
Grabowski Mary Kate et al. Current HIV/AIDS reports 2018 Feb (Posted: Mar 05, 2018 9AM)

Transmission fitness of drug-resistant HIV revealed in a surveillance system transmission network
JO Wetheim et al, Virus Evolution, April 19, 2017 (Posted: Apr 23, 2017 7AM)

National Youth HIV & AIDS Awareness Day
Brand (Posted: Apr 10, 2017 10AM)

World AIDS Day 2016
Brand (Posted: Nov 30, 2016 1PM)

How researchers cleared the name of HIV Patient Zero
Nature, October 27. 2016 (Posted: Oct 28, 2016 7AM)

Gene study clears 'Patient Zero' as cause of U.S. HIV epidemic
Reuter's Health, October 26, 2016 (Posted: Oct 26, 2016 4PM)

H.I.V. Arrived in the U.S. Long Before ‘Patient Zero’
New York Times, October 26, 2016 (Posted: Oct 26, 2016 3PM)

1970s and ‘Patient 0’ HIV-1 genomes illuminate early HIV/AIDS history in North America
Mo Worobey et al, Nature, October 26, 2016 (Posted: Oct 26, 2016 2PM)

CRISPR Identifies Potential Gene Targets to Hobble HIV Infection
S Begley, Scientific American, October 26, 2016 (Posted: Oct 26, 2016 7AM)

National Gay Men's HIV/AIDS Awareness Day
Brand (Posted: Sep 27, 2016 8AM)

Asian & Pacific Islanders HIV/AIDS Awareness Day
Brand (Posted: May 19, 2016 10AM)

National Native HIV/AIDS Awareness Day
Brand (Posted: Mar 21, 2016 8AM)

Screening Yield of HIV Antigen/Antibody Combination and Pooled HIV RNA Testing for Acute HIV Infection in a High-Prevalence Population
PJ Peters et al JAMA, February 16, 2016 (Posted: Feb 17, 2016 4PM)

February 7 is National HIV/AIDS Day
Brand (Posted: Feb 08, 2016 8PM)

Outcomes of HIV Vaccine Related to Genetic Variation
MJ Friedrich, JAMA, September 15, 2015 (Posted: Sep 16, 2015 10AM)

HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition.
Prentice Heather A et al. Sci Transl Med 2015 Jul 15. (296) 296ra112 (Posted: Sep 16, 2015 10AM)

Bottlenecks in HIV-1 transmission: insights from the study of founder viruses
SB Joseph et al, Nature Reviews Microbiology, June 8, 2015 (Posted: Jun 12, 2015 0PM)

Genome-Wide Association Studies of HIV-1 Host Control in Ethnically Diverse Chinese Populations.
Wei Zejun et al. Sci Rep 2015 10879 (Posted: Jun 09, 2015 3PM)

The impact of host genetic variation on infection with HIV-1.
McLaren Paul J et al. Nat. Immunol. 2015 May 19. (6) 577-583 (Posted: Jun 09, 2015 3PM)

Genome editing-based HIV therapies.
Gu Wan-Gang et al. Trends Biotechnol. 2015 Mar (3) 172-179 (Posted: Mar 30, 2015 7AM)

Application of gene-editing technologies to HIV-1.
Drake Mary Jane et al. Curr Opin HIV AIDS 2015 Mar (2) 123-7 (Posted: Mar 30, 2015 7AM)

Genomics of HIV infection.
Telenti Amalio et al. Curr Opin HIV AIDS 2015 Mar (2) 77-8 (Posted: Mar 30, 2015 6AM)

HIV-1 adaptation to HLA: a window into virus-host immune interactions.
Carlson Jonathan M et al. Trends Microbiol. 2015 Jan 19. (Posted: Mar 30, 2015 6AM)

Data-intensive analysis of HIV mutations.
Ozahata Mina et al. BMC Bioinformatics 2015 Feb 5. (1) 35 (Posted: Mar 30, 2015 6AM)

The Interplay Between Host Genetic Variation, Viral Replication, and Microbial Translocation in Untreated HIV-Infected Individuals.
Perkins Molly R et al. J. Infect. Dis. 2015 Feb 20. (Posted: Mar 30, 2015 6AM)

The impact of HIV-1 genetic diversity on the efficacy of a combinatorial RNAi-based gene therapy.
Herrera-Carrillo E et al. Gene Ther. 2015 Feb 26. (Posted: Mar 30, 2015 6AM)

Genome editing strategies: potential tools for eradicating HIV-1/AIDS.
Khalili Kamel et al. J. Neurovirol. 2015 Feb 26. (Posted: Mar 30, 2015 6AM)

Targeting the HIV RNA Genome: High-Hanging Fruit Only Needs a Longer Ladder.
Le Grice Stuart F J et al. Curr. Top. Microbiol. Immunol. 2015 Mar 4. (Posted: Mar 30, 2015 6AM)

Possible Biomarkers for the Early Detection of HIV-associated Heart Diseases: A Proteomics and Bioinformatics Prediction.
Rasheed Suraiya et al. Comput Struct Biotechnol J 2015 145-52 (Posted: Mar 30, 2015 6AM)

Gene Therapy Strategies to Block HIV-1 Replication by RNA Interference.
Herrera-Carrillo Elena et al. Adv. Exp. Med. Biol. 2015 71-95 (Posted: Mar 30, 2015 6AM)

Editing CCR5: A Novel Approach to HIV Gene Therapy.
Cornu Tatjana I et al. Adv. Exp. Med. Biol. 2015 117-30 (Posted: Mar 30, 2015 6AM)

HIV Latency and the Noncoding RNA Therapeutic Landscape.
Saayman Sheena et al. Adv. Exp. Med. Biol. 2015 169-89 (Posted: Mar 30, 2015 6AM)

Novel Genetic Locus Implicated for HIV-1 Acquisition with Putative Regulatory Links to HIV Replication and Infectivity: A Genome-Wide Association Study.
Johnson Eric O et al. PLoS ONE 2015 (3) e0118149 (Posted: Mar 30, 2015 6AM)

An integrated map of HIV genome-wide variation from a population perspective.
Li Guangdi et al. Retrovirology 2015 (1) 18 (Posted: Mar 30, 2015 6AM)

The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA.
Zhu Weijun et al. Retrovirology 2015 (1) 22 (Posted: Mar 30, 2015 6AM)

Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1 infection in human cells.
Liao Hsin-Kai et al. Nat Commun 2015 6413 (Posted: Mar 30, 2015 6AM)

CDC Information on HIV/AIDS
Brand (Posted: Feb 25, 2015 0PM)

HIV/AIDS
Brand (Posted: Jan 11, 2014 11AM)

HIV, or human immunodeficiency virus, is the virus that causes AIDS (Acquired Immunodeficiency Syndrome). HIV attacks the immune system by destroying CD4 positive (CD4+) T cells, a type of white blood cell that is vital to fighting off infection. The destruction of these cells leaves people infected with HIV vulnerable to other infections, diseases and other complications. As the leading U.S. government institute for HIV/AIDS research, NIAID is committed to conducting the research necessary to successfully end the fight against HIV/AIDS.

Sexually Transmitted Diseases
Brand (Posted: Jan 11, 2014 11AM)

Sexually transmitted diseases (STDs) are infections transmitted from an infected person to an uninfected person through sexual contact. STDs can be caused by bacteria, viruses, or parasites. Examples include gonorrhea, genital herpes, human papillomavirus infection, HIV/AIDS, chlamydia, and syphilis.

Pneumonia
From NHLBI health topic site Brand (Posted: Jan 01, 2014 0AM)

Pneumonia is a bacterial, viral, or fungal infection of one or both sides of the lungs that causes the air sacs, or alveoli, of the lungs to fill up with fluid or pus. Symptoms can be mild or severe and may include a cough with phlegm (a slimy substance), fever, chills, and trouble breathing. Many factors affect how serious pneumonia is, such as the type of germ causing the lung infection, your age, and your overall health. Pneumonia tends to be more serious for children under the age of five, adults over the age of 65, people with certain conditions such as heart failure, diabetes, or COPD (chronic obstructive pulmonary disease), or people who have weak immune systems due to HIV/AIDS, chemotherapy (a treatment for cancer), or organ or blood and marrow stem cell transplant procedures. To diagnose pneumonia, your doctor will review your medical history, perform a physical exam, and order diagnostic tests. This information can help your doctor determine what type of pneumonia you have. If your doctor suspects you got your infection while in a hospital, you may be diagnosed with hospital-acquired pneumonia. If you have been on a ventilator to help you breathe, you may have ventilator-associated pneumonia. The most common form of pneumonia is community-acquired pneumonia, which is when you get an infection outside of a hospital. Treatment depends on whether bacteria, viruses, or fungi are causing your pneumonia. If bacteria are causing your pneumonia, you usually are treated at home with oral antibiotics. Most people respond quickly to treatment. If your symptoms worsen you should see a doctor right away. If you have severe symptoms or underlying health problems, you may need to be treated in a hospital. It may take several weeks to recover from pneumonia. Explore this Health Topic to learn more about pneumonia, our role in research and clinical trials to improve health, and where to find more information.


Disclaimer: Articles listed in Hot Topics of the Day are selected by Public Health Genomics Branch to provide current awareness of the scientific literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the Clips, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
TOP